Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOFlipid for Neonates with PN-Induced Liver Injury
NCT02721277Phase 2Terminated
- Sponsor
- University of Florida
- Start
- May 2016
- Primary completion
- Dec 2016
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of SMOFlipid in Parenteral Nutrition Associated Liver Disease (PNALD), sponsored by University of Florida. Started May 2016; status: terminated.
02
Drugs
SMOFlipid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)
Beyond the preview
Go deeper on NCT02721277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02721277.